Literature DB >> 21629613

New antibacterials?

Kevin B Laupland1, David N Fisman.   

Abstract

Year:  2010        PMID： 21629613      PMCID： PMC2912108          DOI： 10.1155/2010/602510

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  17 in total

Review 1.  Why is big Pharma getting out of antibacterial drug discovery?

Authors:  Steven J Projan
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

Review 2.  Source control in the management of severe sepsis and septic shock: an evidence-based review.

Authors:  John C Marshall; Ronald V Maier; Maria Jimenez; E Patchen Dellinger
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

Review 3.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

Review 4.  Late stage antibacterial drugs in the clinical pipeline.

Authors:  Steven J Projan; Patricia A Bradford
Journal:  Curr Opin Microbiol       Date:  2007-10-22       Impact factor: 7.934

Review 5.  Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.

Authors:  Kevin B Laupland; Andrew W Kirkpatrick; Anthony Delaney
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

Review 6.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

7.  Practical Problems in the Serum Therapy of Meningococcus Meningitis.

Authors:  A Wadsworth
Journal:  Am J Public Health Nations Health       Date:  1931-02

8.  Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Authors:  Henry Shinefield; Steven Black; Ali Fattom; Gary Horwith; Scott Rasgon; Juan Ordonez; Hock Yeoh; David Law; John B Robbins; Rachel Schneerson; Larry Muenz; Steve Fuller; Joanie Johnson; Bruce Fireman; Harry Alcorn; Robert Naso
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

9.  Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario.

Authors:  Kaede V Ota; Frances Jamieson; David N Fisman; Karen E Jones; Itamar E Tamari; Lai-King Ng; Lynn Towns; Prasad Rawte; Alessandro Di Prima; Tom Wong; Susan E Richardson
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

Review 10.  Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.

Authors:  G Cornaglia; G M Rossolini
Journal:  Clin Microbiol Infect       Date:  2009-03       Impact factor: 8.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.